ANXA2 and breast carcinoma: In addition, Zhang [73] has shown that the knockdown of ANXA2 in MDA-MB-435s cells downregulates the levels of plasmin, S100A10, and c-Myc and inhibits breast cancer proliferation and invasion [55].